Medicare Rx Benefit "More Significant" Than Waxman/Hatch Reform - Barr
Executive Summary
Enactment of a Medicare prescription drug benefit is a higher priority for generic drug companies than reforms to the Waxman/Hatch Act, Barr CEO Bruce Downey told analysts Aug. 7.
You may also be interested in...
Pfizer Estrostep Fe Is Barr's Next Patent Challenge; Ortho-Novum Trial By Oct.
Barr's patent challenge against Pfizer's Estrostep Fe is the generic company's latest step in attempting to expand its oral contraceptives franchise.
Pfizer Estrostep Fe Is Barr's Next Patent Challenge; Ortho-Novum Trial By Oct.
Barr's patent challenge against Pfizer's Estrostep Fe is the generic company's latest step in attempting to expand its oral contraceptives franchise.
Duramed Verapamil Production Resumption Expected Within Several Months
Duramed plans to resume manufacturing of the hypertension drug verapamil at its Somerset, N.J. plant in the next few months.